Clinical Trials - In Development

The clinical trials listed in this section are in start-up and not yet open to recruitment. For each trial, an overview of the study design is provided together with a brief explanation of the trial objectives. Members can review the Trial Report in the Members Area.

Filter AGITG trials by

A phase II trial of neoadjuvant PD-1 vaccine IMU-201 (PD1-Vaxx) in operable MSI high colon and rectal cancer (CRC). Read More

Developing and applying artificial intelligence (AI) based image analysis for scoring PD-L1 immunohistochemistry in gastric cancer Read More

This study will investigate both Sacral nerve stimulation (SNS) and Transanal irrigation (TAI) in patients with severe low anterior resection syndrome (LARS) symptoms against non-surgical management. The trial will investigate whether these treatments can improve patients’ symptoms, QoL and investigate the cost implications. Read More

STOPNET - Comparison of patient outcomes with or without continuation of somatostatin injections after the commencement of Peptide Receptor Radionuclide Therapy (PRRT) Read More

BIOMARCER-2 - Biomarker informed optimal management of advanced RAS wild type colorectal cancer in right sided disease Read More

A translational substudy of NEO-IMPACT to investigate the longitudinal evolution of the pancreas cancer microbiome when exposed to chemo-immunotherapy pre-operatively. Read More